- Home
- ATXS vs VALU Comparison
ATXS vs VALU Comparison
Compare ATXS & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- VALU
- Stock Information
- Founded
- ATXS 2008
- VALU 1931
- Country
- ATXS United States
- VALU United States
- Employees
- ATXS N/A
- VALU N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- VALU Investment Managers
- Sector
- ATXS Health Care
- VALU Finance
- Exchange
- ATXS Nasdaq
- VALU Nasdaq
- Market Cap
- ATXS 424.4M
- VALU 345.7M
- IPO Year
- ATXS 2015
- VALU N/A
- Fundamental
- Price
- ATXS $7.52
- VALU $38.94
- Analyst Decision
- ATXS Buy
- VALU
- Analyst Count
- ATXS 6
- VALU 0
- Target Price
- ATXS $33.00
- VALU N/A
- AVG Volume (30 Days)
- ATXS 436.6K
- VALU 5.8K
- Earning Date
- ATXS 11-12-2025
- VALU 09-15-2025
- Dividend Yield
- ATXS N/A
- VALU 3.34%
- EPS Growth
- ATXS N/A
- VALU 6.17
- EPS
- ATXS N/A
- VALU 2.26
- Revenue
- ATXS N/A
- VALU $34,801,000.00
- Revenue This Year
- ATXS N/A
- VALU N/A
- Revenue Next Year
- ATXS N/A
- VALU N/A
- P/E Ratio
- ATXS N/A
- VALU $17.25
- Revenue Growth
- ATXS N/A
- VALU N/A
- 52 Week Low
- ATXS $3.56
- VALU $32.94
- 52 Week High
- ATXS $12.52
- VALU $57.68
- Technical
- Relative Strength Index (RSI)
- ATXS 55.75
- VALU 54.92
- Support Level
- ATXS $6.95
- VALU $38.63
- Resistance Level
- ATXS $7.48
- VALU $39.59
- Average True Range (ATR)
- ATXS 0.42
- VALU 0.71
- MACD
- ATXS -0.01
- VALU 0.09
- Stochastic Oscillator
- ATXS 65.35
- VALU 72.22
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.